MZ 1 is primarily utilized in the field of biomedical research, particularly in the study of protein degradation and cellular processes. It functions as a selective degrader of BRD4, a protein involved in the regulation of gene expression. By targeting BRD4 for degradation, MZ 1 helps researchers investigate the role of this protein in various diseases, including cancer. Its application is crucial in developing targeted therapies that can disrupt specific protein functions without affecting other cellular mechanisms. This makes MZ 1 a valuable tool in understanding disease pathways and in the development of novel therapeutic strategies.